Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate (III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells

European Journal of Cancer

Volumn 33, Issue 14, 1997, Pages 2404-2410

  Depenbrock, H ^a   Schmelcher, S ^a   Peter, R ^a   Keppler, B K ^b   Weirich, G ^a   Block, T ^a   Rastetter, J ^a   Hanauske, A R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Clonogenic growth; Human tumours; Ruthenium complexes

Indexed keywords

INDAZOLE DERIVATIVE; INDAZOLIUM TETRACHLOROBIS(INDAZOLE)RUTHENATE; NSC 666158; RUTHENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; KIDNEY CANCER; LUNG CANCER; PRIORITY JOURNAL;

CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMATOPOIETIC STEM CELLS; HUMANS; INDAZOLES; ORGANOMETALLIC COMPOUNDS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR STEM CELLS;

EID: 0031415671     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00277-3     Document Type: Article

References (16)

1. Berger MR, Garzon FT, Keppler BK, Schmähl D. Efficacy of new ruthenium complexes against chemically-induced autochthonous colorectal carcinoma in rats. Anticancer Res. 9:1989;761-765.
2. Frühauf S, Zeller WJ. In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and -resistant rat ovarian tumors. Cancer Chemother Pharmacol. 27:1991;301-307.
3. Galeano A, Berger MR, Keppler BK. Antitumor activity of some ruthenium derivatives in human colon cancer cell lines in vitro. Arzneimittelforschung. 42:1992;821-824.
4. Keppler BK, Berger MR, Heim ME. New tumor-inhibiting metal complexes. Cancer Treat Rev. 17:1990;261-277.
5. Seelig MH, Berger MR, Keppler BK. Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats. J Cancer Res Clin Oncol. 118:1992;195-200.
6. Keppler BK, Lipponer KG, Stenzel B, et al. New tumor-inhibiting ruthenium complexes. In Keppler BK, ed. Metal Complexes in Cancer Chemotherapy. Weinheim, New York, Basel, Cambridge, Tokyo, VCG, 1993, 187-220.
7. Clarke MJ. Ruthenium chemistry pertaining to the design of anticancer agents. Prog Clin Biochem Med. 10:1989;25-39.
8. Klausner RD, van Renswoude J, Ashwell G, et al. Receptor-mediated endocytosis of transferrin in K562 cells. J Biol Chem 1983, 258, 4715-4724.
9. Frühauf S, Zeller WJ. New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells. Cancer Res. 51:1991;2943-2948.
10. Alberts DS, Chen HSG. Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. In Salmon S, ed. Cloning of Human Tumor Cells. New York, Alan R. Liss, 1980, 351-359.
11. Hanauske A-R, Hanauske U, Von Hoff DD. The human tumor cloning assay in cancer research and therapy. Curr Probl Cancer. 9:1985;1-50.
12. Maurer HR, Ali-Osman F. Tumor stem cell cloning in agar-containing capillaries. Naturwiss. 68:1981;381-383.
13. Von Hoff DD, Forseth BJ, Huong M, Buchok JB, Lathan B. Improved plating efficiencies for human tumors cloned in capillary tubes versus Petri dishes. Cancer Res. 46:1986;4012-4017.
14. Hanauske U, Hanauske A-R, Marshall MH, Muggia VA, Von Hoff DD. Biphasic effects of vanadium salts on in vitro tumor colony growth. Int J Cell Cloning. 5:1987;170-178.
15. Keppler BK, Berger MR, Klenner T, Heim ME. Metal complexes as antitumour agents. Advances Drug Res. 19:1990;243-310.
16. Kreuser ED, Keppler BK, Berdel WE, Piest A, Thiel E. Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines. Semin Oncol. 19:1992;73-81.